Key Points
- Director Joseph Tautges sold 7,800 shares of Ambiq Micro on Jan. 26 at an average of $31 for $241,800, leaving him with 48,746 shares (a 13.79% reduction); the sale was disclosed in an SEC filing.
- AMBQ shares were trading higher (opened $32.84) with a 12‑month range of $22.12–$51.76, a market cap of about $601.3M and a negative P/E of -1.66; the company reported Q3 EPS of ($0.39) (beat) and set Q4 2025 guidance of -0.440 to -0.340.
- Analysts are mixed but consensus is Hold, with an average price target of about $41.75 (2 Buy, 3 Hold, 1 Sell).
Ambiq Micro, Inc. (NYSE:AMBQ - Get Free Report) Director Joseph Tautges sold 7,800 shares of the stock in a transaction on Monday, January 26th. The stock was sold at an average price of $31.00, for a total value of $241,800.00. Following the completion of the sale, the director directly owned 48,746 shares in the company, valued at approximately $1,511,126. This represents a 13.79% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link.
Ambiq Micro Trading Up 4.7%
Shares of AMBQ opened at $32.84 on Thursday. Ambiq Micro, Inc. has a 12 month low of $22.12 and a 12 month high of $51.76. The stock has a market cap of $601.34 million and a P/E ratio of -1.66. The company's fifty day simple moving average is $29.72.
Ambiq Micro (NYSE:AMBQ - Get Free Report) last announced its quarterly earnings results on Thursday, November 6th. The company reported ($0.39) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.47) by $0.08. Ambiq Micro has set its Q4 2025 guidance at -0.440--0.340 EPS.
Analyst Upgrades and Downgrades
Several analysts recently commented on AMBQ shares. UBS Group cut their price objective on Ambiq Micro from $40.00 to $32.00 and set a "neutral" rating for the company in a report on Monday, October 27th. Wall Street Zen raised shares of Ambiq Micro from a "sell" rating to a "hold" rating in a report on Saturday, November 8th. Finally, Weiss Ratings initiated coverage on shares of Ambiq Micro in a research note on Thursday, October 23rd. They set a "sell (e-)" rating on the stock. Two analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $41.75.
Check Out Our Latest Stock Analysis on AMBQ
Institutional Trading of Ambiq Micro
A number of hedge funds and other institutional investors have recently modified their holdings of AMBQ. Squarepoint Ops LLC bought a new position in shares of Ambiq Micro in the third quarter worth about $277,000. BNP Paribas Financial Markets purchased a new position in Ambiq Micro in the 3rd quarter worth approximately $28,000. JPMorgan Chase & Co. bought a new position in Ambiq Micro in the 3rd quarter worth approximately $56,000. Rhumbline Advisers purchased a new stake in Ambiq Micro during the 3rd quarter valued at approximately $119,000. Finally, Ghisallo Capital Management LLC purchased a new position in Ambiq Micro during the third quarter valued at $598,000.
Ambiq Micro Company Profile
(
Get Free Report)
Ambiq Micro (NYSE: AMBQ) is a semiconductor company specializing in the design and development of ultra-low-power microcontroller units (MCUs) and application-specific integrated circuits (ASICs). The company's core technology leverages sub-threshold voltage operation to dramatically reduce energy consumption, enabling extended battery life in a broad range of portable and always-on devices. Ambiq's products are particularly well suited for applications where power efficiency is critical, such as wearable electronics, IoT sensors, medical monitoring equipment, and industrial automation systems.
The company's flagship product family, the Apollo series of MCUs, offers multi-core architectures, integrated wireless connectivity options, and advanced security features.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
